There are 2789 resources available
487P - Targeting PDL-1 in colon cancer using nuclear receptor 4A1 (NR41) antagonist
Presenter: Maen Abdelrahim
Session: ePoster Display
489P - MEN1611 in combination with cetuximab: Targeting PIK3CA mutations in RAS-wild-type patient-derived colorectal cancer xenografts
Presenter: Stefania Capano
Session: ePoster Display
490P - New horizons in metastatic colorectal cancer: Role of CD44 expression
Presenter: Pina Ziranu
Session: ePoster Display
491P - Lipid-engulfed macrophages at the root of gut carcinogenesis
Presenter: Elena Daveri
Session: ePoster Display
492P - Vitamin D deficiency in metastatic colorectal cancer (mCRC) worsens survival and correlates with significant peripheral inflammatory/immune cell changes
Presenter: Michela Rofei
Session: ePoster Display
493P - Impact of age on the activity of aflibercept plus FOLFIRI in metastatic colorectal cancer (mCRC): Real world data from the QoLiTrap study
Presenter: Josef Thaler
Session: ePoster Display
494P - Early-onset colorectal cancer: 10-year cases documented in a comprehensive cancer centre illustrate the importance of a growing oncological problem
Presenter: Jose Carlos Ruffinelli
Session: ePoster Display
495P - Clinical characteristics, prognostic factors and survival of early-onset colorectal cancer (EOCRC) in a Spanish cohort
Presenter: Javier Soto Alsar
Session: ePoster Display
447P - The prognostic factors in early stage BRAF mutant colorectal cancer: Experience from a large volume UK tertiary centre
Presenter: Justin Mencel
Session: ePoster Display
448P - Efficacy of combinations of BRAF inhibitors and anti-EGFR antibodies in metastatic colorectal carcinoma (mCRC) patients with mBRAF in the real clinical practice
Presenter: Mikhail Fedyanin
Session: ePoster Display